Sign Up for a Free Account
  • Updated 03.11.2024
  • Released 06.28.2006
  • Expires For CME 03.11.2027

Sjogren syndrome: neurologic complications



Neurologic involvement is a systemic manifestation of primary Sjögren syndrome that may involve the central, peripheral, and autonomous nervous systems. The frequency of neurologic involvement is relatively unknown, although the Big Data Sjögren Syndrome Cohort reported a frequency of 6.3% for peripheral neuropathies and 1.9% for central nervous system, according to The European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) definitions (105). Neurologic involvement often precedes the typical glandular manifestations of Sjögren syndrome and has a wide spectrum of manifestations and underlying neuropathologic mechanisms, making the diagnosis and approach to treatment a difficult challenge that requires a multidisciplinary approach. The diagnosis and treatment of these manifestations always must be coordinated by neurologists. The level of evidence for treatment efficacy of the main drugs used for managing neuroSjogren is limited.

Key points

• Sjögren syndrome is a common systemic autoimmune disease, mainly diagnosed in women aged 30 to 50 years old, which is manifested by sicca symptoms and organ-specific systemic involvement.

• Neurologic symptoms occur in 18% to 45% of patients with Sjögren syndrome due to involvement of cranial nerves (Bell palsy, trigeminal neuralgia, diplopia), peripheral nerves (sensorimotor neuropathies), and the central nervous system.

• Other neurologic diseases have to be excluded in patients with Sjögren presenting with neurologic symptoms before considering CNS involvement as specific to primary Sjögren syndrome.

• A high index of suspicion is required given the pleomorphic manifestations and the fact that neurologic symptoms often precede the clinical diagnosis of Sjögren syndrome.

Historical note and terminology

In 1933, Henrik Sjögren described the association of keratoconjunctivitis sicca (filamentary keratitis) with arthritis (127). Morgan and Castleman noted the histopathological commonality between the keratitis described by Sjögren and the glandular enlargement described by Mikulicz (87; 85). By 1973, the term “Sjögren syndrome” became widely accepted as these disorders were considered variants of the same process (79). The name Gougerot-Sjögren syndrome is commonly used in the French literature (29) given that Henry Gougerot first reported, in Paris, the typical symptoms of xerostomia and xerophthalmia due to atrophy of salivary and lachrymal glands (47).

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125